Trexquant Investment LP Zymeworks Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.43 $180,020 - $287,645	38,714 Added 70.25%	93,824 $577,000
Q2 2022 Aug 11, 2022	BUY	$4.82 - $7.7 $265,630 - $424,347	55,110 New	55,110 $292,000
Q1 2021 May 13, 2021	SELL	$29.83 - $56.81 $169,613 - $323,021	-5,686 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$39.12 - $54.99 $222,436 - $312,673	5,686 New	5,686 $269,000
Q3 2020 Nov 06, 2020	SELL	$29.21 - $46.58 $455,325 - $726,089	-15,588 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$33.67 - $40.0 $524,847 - $623,520	15,588 New	15,588 $562,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $903M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.